Education
About Us
Working with TipRanks
Follow Us
Ian Jeffrey Constable Insider Profile
4 Followers
Ian Jeffrey Constable, Director at PYC Therapeutics Limited, holds 328.00K shares in PYC Therapeutics Limited (Ticker: AU:PYC). Most recently, Ian Jeffrey Constable Bought 123,000 shares of PYC Therapeutics Limited on Mar 10, 2026 for an estimated value of AU$184.50K.
Ian Jeffrey Constable has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Ian Jeffrey Constable's holdings
Insider Roles
Director
Roles that Ian Jeffrey Constable holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Ian Jeffrey Constable
Ian Jeffrey Constable's Trading History
List of latest transactions for each holding click on a transaction to see Ian Jeffrey Constable's performance on stock
You May Also Like
Ian Jeffrey Constable insider profile FAQ
What is the percentage of profitable transactions made by Ian Jeffrey Constable?
The percentage of profitable transactions made by Ian Jeffrey Constable is ―.
What is the average return per transaction made by Ian Jeffrey Constable?
The average return per transaction made by Ian Jeffrey Constable is ―.
What stocks does Ian Jeffrey Constable hold?
Ian Jeffrey Constable holds: AU:PYC stocks.
What was Ian Jeffrey Constable’s latest transaction?
Ian Jeffrey Constable latest transaction was an Informative Buy of AU$184.50K.
What was Ian Jeffrey Constable's most profitable transaction?
Ian Jeffrey Constable’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Ian Jeffrey Constable's role in PYC Therapeutics Limited?
Ian Jeffrey Constable's role in PYC Therapeutics Limited is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.